Articles From: Infinity Provides Key 2015 Goals and Financial Guidance to Akebia Therapeutics, Inc. Added to NASDAQ Biotechnology Index


Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its anticipated pipeline goals and provided financial guidance for 2015.
Sign-up for Infinity Provides Key 2015 Goals and Financial Guidance investment picks
Retrophin, Inc. (NASDAQ:RTRX) and Asklepion Pharmaceuticals, LLC, a privately held rare disease pharmaceutical development company, today announced the signing of a definitive agreement under which Retrophin has acquired the exclusive right to purchase from Asklepion, all worldwide rights, titles, and ownership of cholic acid for the treatment of bile acid synthesis defects, if approved by the U.S. Food and Drug Administration (FDA). Under the terms of the agreement, Retrophin will pay Asklepion an upfront payment of $5 million and up to $73 million in milestones based on approval and net product sales, plus tiered royalties on future net sales of cholic acid.
Sign-up for Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals investment picks
GREENWICH, Conn.
Sign-up for PartyLite Products Now Available In The Direct Selling Market In Korea investment picks
Myers Industries, Inc. (NYSE:MYE), an international manufacturer of polymer products and wholesale distributor servicing the under vehicle service industry in the U.S., announced today that it has entered into a definitive agreement to sell its Lawn & Garden business for $115 million to an entity controlled by Wingate Partners V, L.P., a Dallas, TX based private equity firm.
Sign-up for Myers Industries Enters into Definitive Agreement to Sell Its Lawn & Garden Business investment picks
Sandell Asset Management Corporation (“Sandell”), one of the largest shareholders of Bob Evans Farms, Inc. (NASDAQ:BOBE) (“Bob Evans” or the “Company”), today commented on the Company’s announcement of senior leadership changes, including the stepping down of Steven Davis as CEO: “As one of the largest shareholders of Bob Evans, we are pleased the Board has agreed with our view that a management change was needed at the Company, and has acted decisively on this belief,” said Tom Sandell, CEO of Sandell Asset Management.
Sign-up for Sandell Comments on Leadership Change at Bob Evans investment picks
PITTSBURGH , Dec.
Sign-up for Month-End Portfolio Data Now Available for Federated Investors' Closed-End Funds investment picks
GE Aviation has been selected by The Boeing Company to provide the Common Core System (CCS) and the Enhanced Airborne Flight Recorder (EAFR) for the Boeing 777X aircraft.
Sign-up for Boeing Selects GE Aviation for 777X Common Core Avionics Systems investment picks
The Board of Directors of Park Electrochemical Corp.
Sign-up for Park Electrochemical Corp. Declares Cash Dividend investment picks
- Anthera to receive up to $48,000,000 plus future product margin on commercial supply - Zenyaku to reimburse Anthera for a portion of future blisibimod worldwide development costs - Zenyaku to assume full responsibility for development and associated costs in Japan and potentially other Asian territories in the future - Companies will collaborate on blisibimod development for both IgA Nephropathy ("IgAN") and Systemic Lupus Erythematosus ("Lupus") HAYWARD, Calif.
Sign-up for Anthera Pharmaceuticals Licenses Japan Rights for Blisibimod to Zenyaku Kogyo Co., Ltd. investment picks
AGCO, Your Agriculture Company, (NYSE:AGCO), a worldwide manufacturer and distributor of agricultural equipment, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s common stock.
Sign-up for AGCO Announces New $500 Million Share Repurchase Program investment picks
Digital Benefit Advisors (DBA) ( digitalbenefitadvisors.com ), a national employee benefits-only alliance with 25 offices across the country, including three in Virginia, has launched a specialized long-term disability product designed specifically for physicians in group practices throughout Virginia.
Sign-up for Digital Benefit Advisors Launches Specialized Long-Term Disability Product for Virginia Physicians in Group Practices investment picks
- $400 million investment to develop natural gas gathering and compression in southeastern Ohio - Establishes Summit Investments as a midstream operator in the Utica Shale, complementing its existing 40% interest in Ohio Gathering joint venture - Increases Summit Investments' development backlog to more than $2.0 billion DALLAS , Dec.
Sign-up for General Partner of Summit Midstream Partners, LP To Develop Natural Gas Gathering System for XTO Energy Inc. in the Utica Shale investment picks
CHATSWORTH, Calif., Dec.
Sign-up for Capstone Turbine Secures Substantial Order for Mexican Pipeline Project investment picks
SALT LAKE CITY, Dec.
Sign-up for FDA Confirms Lipocine's Previously-Agreed Clinical Development Plan for LPCN 1021 investment picks
TEMPE, Ariz., Dec.
Sign-up for Insight Recognized as a 2014 "Best Place to Work" investment picks
System will be used to Demonstrate Manure Processing Capabilities and Launch Market TAMPA, Fla.
Sign-up for MagneGas Deploys Manure Sterilization System to Major Hog Farm investment picks
http://media.marketwire.com/attachments/201307/63937_Clipboard01.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164922&ProfileId=051205&sourceType=1 LYON, FRANCE --
Sign-up for Flamel Technologies to Be Included in NASDAQ Biotech Index investment picks
BURLINGTON, Mass., Dec.
Sign-up for CB Pharma Acquisition Corp. Announces Pricing of Initial Public Offering investment picks
Acceleron Pharma Inc. (NASDAQ: XLRN), a biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it has been selected for addition to the NASDAQ Biotechnology Index ® (NASDAQ: NBI), effective Monday, December 22, 2014.
Sign-up for Acceleron Pharma Added to NASDAQ Biotechnology Index investment picks
Sierra Wireless (NASDAQ:SWIR) (TSX:SW) today announced that the company will be added to the S&P/TSX Composite Index in Canada, effective December 19, 2014 after market close.
Sign-up for Sierra Wireless Announces Inclusion in the S&P/TSX Composite Index in Canada investment picks
http://media.marketwire.com/attachments/201307/174504_RMGNetworks.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164864&ProfileId=051205&sourceType=1 DALLAS, TX --
Sign-up for RMG Networks Awarded $2.5 Million Internal Communications Contract investment picks
STORE Capital Corporation (NYSE: STOR), an internally managed net-lease real estate investment trust (REIT) that invests in S ingle T enant O perational R eal E state, today announced a regular quarterly cash dividend on its common stock of $0.1139 per share for the fourth quarter ending December 31, 2014.
Sign-up for STORE Capital Declares Pro Rata Fourth Quarter 2014 Dividend investment picks
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that it has been selected for addition to the NASDAQ Biotechnology Index ® (Nasdaq:^NBI). The annual re-ranking of the NASDAQ Biotechnology Index will become effective upon market open on Monday, December 22, 2014.
Sign-up for Akebia Therapeutics, Inc. Added to NASDAQ Biotechnology Index investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Infinity Provides Key 2015 Goals and Financial Guidance to Akebia Therapeutics, Inc. Added to NASDAQ Biotechnology Index
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent